Scientists uncover hidden inherited form of aggressive prostate cancer

- ✦The discovery, by researchers at the University of British Columbia (UBC), Canada, has identified inherited mutations in a gene known as CDK12 as a potential cause of exceptionally aggressive prostate cancer, challenging the long-held belief that changes in the gene occur only within cancer cells during tumour development.
- By Sola Ogundipe A man could inherit a genetic mutation that silently puts him at risk of an aggressive form of prostate cancer, develop the disease in his 40s and discover it only after the cancer has spread beyond the prostate.
- Scientists say they have uncovered a previously unknown hereditary pathway that could help explain some of these devastating cases.
- The discovery, by researchers at the University of British Columbia (UBC), Canada, has identified inherited mutations in a gene known as CDK12 as a potential cause of exceptionally aggressive prostate cancer, challenging the long-held belief that changes in the gene occur only within cancer cells during tumour development.
Beyond prostate cancer, the researchers also uncovered evidence suggesting inherited CDK12 mutations may be associated with ovarian cancer
Frequently Asked Questions About This Story
What is the key takeaway from this report?
By Sola Ogundipe A man could inherit a genetic mutation that silently puts him at risk of an aggressive form of prostate cancer, develop the disease in his 40s and discover it only after the cancer has spread beyond the prostate.
What additional context is highlighted in this report?
Scientists say they have uncovered a previously unknown hereditary pathway that could help explain some of these devastating cases.
What are the broader implications of this development?
The discovery, by researchers at the University of British Columbia (UBC), Canada, has identified inherited mutations in a gene known as CDK12 as a potential cause of exceptionally aggressive prostate cancer, challenging the long-held belief that changes in the gene occur only within cancer cells during tumour development.